Concepedia
Statistics
Publications
15
Citations
1.5K
H-Index
13
Active since
2001
Affiliations
Harvard University(Current)
McGill University
University of Toronto
Moderna Therapeutics (United States)
Seqirus (United States)
Michele Kohli is an author at Harvard University specializing in vaccination, immunization, and vaccine effectiveness.
Publications per year
2001–2023
Projected Clinical Benefits and Cost-effectiveness of a Human Papillomavirus 16/18 Vaccine
S. J. Goldie, Michele Kohli, Daniel Grima et al. · JNCI Journal of the National Cancer Institute · 2004 · 537 citations
Veterinary Medicine, Oncology, Preventive Medicine +17
A comprehensive natural history model of HPV infection and cervical cancer to estimate the clinical impact of a prophylactic HPV‐16/18 vaccine
Sue J. Goldie, Daniel Grima, Michele Kohli et al. · International Journal of Cancer · 2003 · 214 citations
Medicine, Oncology, Preventive Medicine +17
The burden of illness of severe nausea and vomiting of pregnancy in the United States
Cheryl Attard, Michele Kohli, Suzanne Coleman et al. · American Journal of Obstetrics and Gynecology · 2002 · 203 citations
Public Health, Maternal Health, Obstetrics +14
The potential public health and economic value of a hypothetical COVID-19 vaccine in the United States: Use of cost-effectiveness modeling to inform vaccination prioritization
Michele Kohli, Michael Maschio, Debbie Becker et al. · Vaccine · 2021 · 151 citations · Full text
Pharmacy, Infectious Diseases, Pharmacoeconomics +17
Estimating the long-term impact of a prophylactic human papillomavirus 16/18 vaccine on the burden of cervical cancer in the UK
Michele Kohli, Nicole Ferko, Aurélie Martin et al. · British Journal of Cancer · 2006 · 113 citations · Full text
1–5 of 15